0001415889-24-005065.txt : 20240223 0001415889-24-005065.hdr.sgml : 20240223 20240223170023 ACCESSION NUMBER: 0001415889-24-005065 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240221 FILED AS OF DATE: 20240223 DATE AS OF CHANGE: 20240223 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: SALEKI-GERHARDT AZITA CENTRAL INDEX KEY: 0001563545 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35565 FILM NUMBER: 24672329 MAIL ADDRESS: STREET 1: 1 N. WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AbbVie Inc. CENTRAL INDEX KEY: 0001551152 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 320375147 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 BUSINESS PHONE: (847) 932-7900 MAIL ADDRESS: STREET 1: 1 NORTH WAUKEGAN ROAD CITY: NORTH CHICAGO STATE: IL ZIP: 60064 4 1 form4-02232024_050201.xml X0508 4 2024-02-21 0001551152 AbbVie Inc. ABBV 0001563545 SALEKI-GERHARDT AZITA 1 N. WAUKEGAN ROAD NORTH CHICAGO IL 60064 false true false false EVP, CHIEF OPERATIONS OFFICER 0 Common Stock, $0.01 par value 2024-02-21 4 M 0 52870 58.88 A 296814 D Common Stock, $0.01 par value 2024-02-21 4 S 0 52870 173.71 D 243944 D Common Stock, $0.01 par value 2322 I Profit sharing trust Common Stock, $0.01 par value 3873 I By spouse Option (Right to Buy) 58.88 2024-02-21 4 M 0 52870 58.88 D 2016-02-19 2025-02-18 Common Stock 52870 0 D The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.51 to $174.03, inclusive. The reporting person undertakes to provide AbbVie Inc., any security holder of AbbVie Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Balance in AbbVie Savings program as of January 31, 2024. The reporting person disclaims beneficial ownership of all securities held by her spouse. Employee stock option granted pursuant to the AbbVie 2013 Incentive Stock Program in a transaction exempt from Section 16 under Rule 16b-3. T.O. Odutayo, attorney-in-fact for Azita Saleki-Gerhardt 2024-02-23